Bigelovii A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Blocking NF-κB and CCAAT/Enhancer-Binding Protein δ Pathways

Optimal methods are applied to acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS), but the mortality rate is still high. Accordingly, further studies dedicated to identify novel therapeutic approaches to ALI are urgently needed. Bigelovii A is a new natural product and may ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Chunguang, Guan, Fuqin, Shen, Yanfei, Tang, Huifang, Yuan, Dong, Gao, Hongwei, Feng, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853956/
https://www.ncbi.nlm.nih.gov/pubmed/27194827
http://dx.doi.org/10.1155/2016/9201604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853956/
https://www.ncbi.nlm.nih.gov/pubmed/27194827
http://dx.doi.org/10.1155/2016/9201604

Ejemplares similares